Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 224

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 224
---
2)Assumes the sale of all common shares being offered pursuant to this prospectus.

(3)All investment decisions for the Selling Shareholder are made by Mr. Mark Angelo. The business address of the Selling Shareholder is 1012 Springfield Avenue, Mountainside, New Jersey 07092.

<div align='center'>154

PLAN OF DISTRIBUTION</div>

Thecommon shares offered by this prospectus are being offered by the Selling Shareholder. The shares may be sold or distributed from time to time by the Selling Shareholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. We will not receive any of the proceeds from the sale of the securities by the Selling Shareholder. We may receive up to $15,000,000 aggregate gross proceeds under the SEPA from any sales we make to the Selling Shareholder pursuant to the SEPA. The net proceeds from sales, if any, under the SEPA, will depend on the frequency and prices at which we sell common shares to the Selling Shareholder after the date of this prospectus.

Thesaleof the common shares offered by thisprospectus could be effected inone or more of the following methods:

ordinarybrokers'transactions;

transactions involving cross or block trades;

through brokers, dealers, or underwriters who may act solely as agents;

"atthe market" into an existing market for our common shares;

in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;

inprivatelynegotiated transactions;or

anycombination of the foregoingor anymanner permitted under applicable law.

In order to comply with the securities laws ofcertainstates, if applicable, theshares may be soldonly through registered or licensed brokers or dealers.

In addition, incertain states,the common shares may not be sold unless they have been registered or qualified for salein the stateor an exemption fromthe state'sregistration or qualificationrequirementis available andcomplied with.

TheSelling Shareholder is an "underwriter" within the meaning of Section 2(a)(11) of the Securities Act.

The Selling Shareholder has informed us that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our common shares that it may acquire from us pursuant to